Fund Holdings — Tri Locum Partners LP

Total Portfolio Value
$288.37M
Total Bought
$174.49M
Total Sold
$93.84M
Net Transaction
+$80.65M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q4 2023
▲▼
Q1 2024
▲▼
Change
▲▼
Q4 2023
▲▼
Q1 2024
▲▼
Weight (%)
▲▼
Change
▲▼
SILK RD MED INC01,083,605+1,083,605019,8526.88%+19,852
MERCK & CO INC(MRK)0119,200+119,200015,7285.45%+15,728
VERTEX PHARMACEUTICALS INC(VRTX)035,598+35,598014,8805.16%+14,880
BAXTER INTL INC0317,566+317,566013,5734.71%+13,573
MERUS N V0286,322+286,322012,8934.47%+12,893
TEVA PHARMACEUTICAL INDS LTD(TEVA)1,794,3352,216,188+421,85318,73331,27010.84%+12,538
TANDEM DIABETES CARE INC(TNDM)0326,506+326,506011,5624.01%+11,562
LEGEND BIOTECH CORP(LEGN)102,215283,773+181,5586,15015,9175.52%+9,767
NATERA INC(NTRA)141,847190,114+48,2678,88517,3886.03%+8,503
MADRIGAL PHARMACEUTICALS INC(MDGL)25,52453,355+27,8315,90614,2484.94%+8,342
AVADEL PHARMACEUTICALS PLC839,9331,189,511+349,57811,86020,0916.97%+8,231
EXACT SCIENCES CORP(EXK)090,000+90,00006,2152.16%+6,215
LYRA THERAPEUTICS INC0978,793+978,79306,0882.11%+6,088
INSPIRE MED SYS INC(INSP)023,566+23,56605,0621.76%+5,062
ALPINE IMMUNE SCIENCES INC0120,687+120,68704,7841.66%+4,784
ASCENDIS PHARMA A/S(ASND)99,550112,670+13,12012,53817,0325.91%+4,494
ARCUTIS BIOTHERAPEUTICS INC(ARQT)0449,694+449,69404,4561.55%+4,456
MIND MEDICINE MINDMED INC0379,596+379,59603,5681.24%+3,568
ARGENX SE(ARGX)24,18227,981+3,7999,20011,0173.82%+1,817
ARCTURUS THERAPEUTICS HLDGS(ARCT)110,470138,927+28,4573,4834,6921.63%+1,208
ASTRIA THERAPEUTICS INC542,945369,549-173,3964,1705,2011.80%+1,032
PRAXIS PRECISION MEDICINES I(PRAX)248,761106,494-142,2675,5426,4982.25%+956
PERSPECTIVE THERAPEUTICS INC(CATX)0780,303+780,30309290.32%+929
FEMASYS INC36,15030,606-5,54435470.02%+12
XENON PHARMACEUTICALS INC(XENE)225,564207,465-18,09910,3898,9313.10%-1,458
AXSOME THERAPEUTICS INC(AXSM)130,738102,711-28,02710,4058,1962.84%-2,209
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)47,6040-47,6042,8750—-2,875
IMMATICS N.V(IMTX)275,4820-275,4822,9010—-2,901
SCHOLAR ROCK HLDG CORP(SRRK)207,1470-207,1473,8940—-3,894
ASTRAZENECA PLC(AZN)58,7870-58,7873,9590—-3,959
REGENERON PHARMACEUTICALS(REGN)16,0128,567-7,44514,0638,2462.86%-5,818
VERONA PHARMA PLC293,1120-293,1125,8270—-5,827
CATALENT INC261,7970-261,79711,7630—-11,763
BIOGEN INC(BIIB)45,8140-45,81411,8550—-11,855
GE HEALTHCARE TECHNOLOGIES I(GEHC)171,6760-171,67613,2740—-13,274
ABBVIE INC(ABBV)167,8070-167,80726,0050—-26,005
Page 1 of 1
Tri Locum Partners LP — 13F Holdings — Q1 2024 | TickerTrail